298 related articles for article (PubMed ID: 2091347)
1. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
[No Abstract] [Full Text] [Related]
2. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM
J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
[TBL] [Abstract][Full Text] [Related]
3. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Hueso M; Bover J; Serón D; Gil-Vernet S; Rufí G; Alsina J; Grinyó JM
Nephrol Dial Transplant; 1999 Dec; 14(12):2941-3. PubMed ID: 10570102
[No Abstract] [Full Text] [Related]
4. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Kuyucu N; Kara C; Bakirtaç A; Teziç T
Pediatr Infect Dis J; 2001 Apr; 20(4):455-7. PubMed ID: 11332679
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
Momeni AZ; Reiszadae MR; Aminjavaheri M
Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
[TBL] [Abstract][Full Text] [Related]
6. Fulminant hepatitis in an Italian infant with visceral leishmaniasis.
di Martino L; Vajro P; Nocerino A; Scotti S; Napolitano G; Vegnente A
Trans R Soc Trop Med Hyg; 1992; 86(1):34. PubMed ID: 1566298
[No Abstract] [Full Text] [Related]
7. Allopurinol in the treatment of American cutaneous leishmaniasis.
Martinez S; Marr JJ
N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
Martínez-Subiela S; Bernal LJ; Cerón JJ
Am J Vet Res; 2003 Aug; 64(8):1021-6. PubMed ID: 12926596
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of leishmaniasis in India.
Thakur CP
Indian J Pediatr; 1987; 54(1):7-10. PubMed ID: 3030933
[No Abstract] [Full Text] [Related]
10. Evaluation of three chemotherapeutic schemes with meglumine antimoniate in the treatment of visceral leishmaniasis in the State of Pará, Brazil.
Marsden PD
Rev Inst Med Trop Sao Paulo; 1993; 35(6):589. PubMed ID: 7997767
[No Abstract] [Full Text] [Related]
11. Treatment of recurrent cutaneous Leishmaniasis.
Momeni AZ; Aminjavaheri M
Int J Dermatol; 1995 Feb; 34(2):129-33. PubMed ID: 7737774
[TBL] [Abstract][Full Text] [Related]
12. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
[No Abstract] [Full Text] [Related]
13. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
Sampaio RN; Marchán EM; Vexenat A; Tristão RJ; Marsden PD
Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
[No Abstract] [Full Text] [Related]
14. Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.
Cascio A; Gradoni L; Scarlata F; Gramiccia M; Giordano S; Russo R; Scalone A; Camma C; Titone L
Am J Trop Med Hyg; 1997 Jul; 57(1):75-8. PubMed ID: 9242323
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis.
da Silva SM; Amorim IF; Ribeiro RR; Azevedo EG; Demicheli C; Melo MN; Tafuri WL; Gontijo NF; Michalick MS; Frézard F
Antimicrob Agents Chemother; 2012 Jun; 56(6):2858-67. PubMed ID: 22411610
[TBL] [Abstract][Full Text] [Related]
16. Treatment of kala azar.
Ozsoylu S
Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
[No Abstract] [Full Text] [Related]
17. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
[No Abstract] [Full Text] [Related]
18. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Ribera E; Ocaña I; de Otero J; Cortes E; Gasser I; Pahissa A
Am J Med; 1996 May; 100(5):496-501. PubMed ID: 8644760
[TBL] [Abstract][Full Text] [Related]
19. Retention of antimony in hair during leishmaniasis treatment.
Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M
Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
